- Home
- OPBK vs FENC Comparison
OPBK vs FENC Comparison
Compare OPBK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPBK | FENC |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | 249 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.9M | 230.8M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | OPBK | FENC |
|---|---|---|
| Price | $14.32 | $9.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $16.50 | $14.50 |
| AVG Volume (30 Days) | 29.2K | ★ 263.7K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ 23.74 | N/A |
| EPS | ★ 0.48 | 0.01 |
| Revenue | $3,204,000.00 | ★ $44,642,000.00 |
| Revenue This Year | $16.07 | $65.12 |
| Revenue Next Year | $11.60 | $41.08 |
| P/E Ratio | ★ $29.92 | $906.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.41 | $5.65 |
| 52 Week High | $15.27 | $10.45 |
Technical Indicators
Market Signals| Indicator | OPBK | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 54.46 |
| Support Level | $13.63 | $8.25 |
| Resistance Level | $14.95 | $9.15 |
| Average True Range (ATR) | 0.37 | 0.49 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 72.28 | 36.21 |
Price Performance
Historical ComparisonAbout OPBK OP Bancorp
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.